Latest News

  • Alkermes Announces Initiation of Clinical Study of Extended Durations of Aripiprazole Lauroxil for Treatment of Schizophrenia Read More
  • Alkermes’ Corporate Presentation to be Webcast at The NASDAQ OMX 31st Investor Program Read More
  • Alkermes’ Corporate Presentation to be Webcast at the Credit Suisse 2014 Healthcare Conference Read More

Investors

Learn More

Working at Alkermes

Join Our Team